跳至主要内容
临床试验/JPRN-jRCTs052180006
JPRN-jRCTs052180006已完成未知

Clinical research of the left ventricular assist device with post-auricular connector - Clinical research of the left ventricular assist device with post-auricular connector

Sawa Yoshiki0 个研究点目标入组 3 人开始时间: 2018年11月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
3

研究概览

简要总结

Of the three cases in which the study was performed, one died (no causal relationship to the study device), one was discontinued, and one was completed at 6 months. None of the patients had DL infection, which is considered a major complication of implantable ventricular assisted device.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • •1) patient who understands the purpose of the study and consents the entry.
  • •2) 20 years old or older.
  • •3) patient and his family understand and consent end-of-life care.
  • •4) severe heart failure patient who needs heart transplantation but is ineligible for it.
  • •5) New York Heart Association Class IIIb and IV end-stage left ventricular failure.
  • •6) patient who has undergone maximum optimal medical therapy but has been demonstrated to be refractory to it.
  • •7) BSA 1.2-2.3m2
  • •8)patient who has a care-giver.

排除标准

  • •1) J-macs profile 1
  • •2) patients who have uncontrollable severe infections.
  • •3) the prognosis of other diseases is less than 3 years.
  • •4) patients who underwent open chest surgery less than 2 weeks before.
  • •5) patients who has contraindication of LVAD implantation due to aortic or ventricular aneurysm, or VSD etc(exclude the cases who can undergo the surgery at the same time).
  • •6) patients who has moderate AR (exclude the cases who can undergo the surgery at the same time).
  • •7) patients with severe cerebral or phsychological disease who can't control LVAD.
  • •8) patients who has a tendency to bleed.
  • •9) pregnant or who wants to became pregnant
  • •10)cirrhosis (Child C)
  • •11) patients who refuse transfusion.
  • •12) patients who has an allergy to bovine products.
  • •13) patients who are participating other clinical studies which affects this study.
  • •14) patients who are considered to be inappropriate
  • •to join this study by the researcher.
  • •15) Patients who can participate in other clinical trials of DT at the time of registration in this study.
  • •16) Patients who are predicted to have difficulty discharging due to right ventricular function and severe heart failure after surgery.
  • •17) Patients who have active inflammatory disease with a history of oral administration of steroids more than 1month within 1 year, or with a current use of steroids. Otherwise, patients whose general condition is severely impaired by systemic wasting disease except for heart failure.

研究者

发起方
Sawa Yoshiki

相似试验

Clinical research of Jarvik-PA | 临床试验